Literature DB >> 10408067

[Radiosynoviorthesis in the treatment plan of chronic inflammatory joint diseases].

A N Savaser1, K T Hoffmann, H Sörensen, D H Banzer.   

Abstract

UNLABELLED: The effectiveness of radiosynovirothesis in the local treatment of chronically inflammatory joint diseases, especially rheumatoid arthritis, was evaluated. SUBJECTS AND METHODS: Follow-up examinations of 415 joints in 115 patients up to 4.5 years after intraarticular application of beta-emitting yttrium-90, rhenium-186, and erbium-169 were evaluated. The examination protocol included estimation of joint circumference, range of active joint moving capability, fist-bending power, and radiological assessment of joint destruction. Subjective assessment of pain, swelling, and joint function by the patients was evaluated by means of a score with three levels.
RESULTS: The mean range of active joint moving capability increased in all joint subgroups, compared with the initial examination, with exception of ankle joints examined more than 30 months after therapy. The mean joint circumference decreased in all joint subgroups. Good to excellent results were achieved in up to 66% of joints, satisfying results in up to 21%, and no improvement or further deterioration was noted in 13% according to subjective assessment by patients themselves. Treatment proved most effective in joints with poor or no alteration in X-ray examinations.
CONCLUSIONS: In the local treatment of chronically inflammatory joint diseases--especially beyond systemic drug therapy and local corticoid therapy--, radiosynoviorthesis is a low-invasive method, which may provide long-term relief of pain and swelling as well as improvement of joint function.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10408067     DOI: 10.1007/s003930050155

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  7 in total

1.  [Unusual digital articular destructions after radio-synovectomy and cortisone injection therapy for Bouchard arthrosis].

Authors:  K Jablonka; J Freyschmidt; C Uhlenbruck
Journal:  Z Rheumatol       Date:  2005-11       Impact factor: 1.372

2.  [The indication for radiosynoviorthesis. From the perspective of the nuclear medicine expert, rheumatic orthopedist and internist].

Authors:  R Linke; K Gelse; F Schuch
Journal:  Z Rheumatol       Date:  2011-01       Impact factor: 1.372

Review 3.  [Radiosynoviorthesis].

Authors:  W Seidel
Journal:  Z Rheumatol       Date:  2006-05       Impact factor: 1.372

Review 4.  Persistent cutaneous ulcers after Yttrium-90 synovectomy, an unusual complication: two case reports and a review of the literature.

Authors:  Lidia García-Colmenero; Gemma Martin-Ezquerra; Jordi Monfort; Ramon M Pujol
Journal:  Int Wound J       Date:  2016-07-21       Impact factor: 3.315

Review 5.  [Minimally invasive therapy of rheumatoid cubarthritis].

Authors:  K Schmidt
Journal:  Z Rheumatol       Date:  2008-10       Impact factor: 1.372

6.  The EANM guideline for radiosynoviorthesis.

Authors:  W U Kampen; B Boddenberg-Pätzold; M Fischer; M Gabriel; R Klett; M Konijnenberg; E Kresnik; H Lellouche; F Paycha; L Terslev; C Turkmen; F van der Zant; L Antunovic; E Panagiotidis; G Gnanasegaran; T Kuwert; T Van den Wyngaert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-10-20       Impact factor: 9.236

7.  Effects of intraarticular (32)P colloid in the treatment of hemophilic synovitis of the knee: A short term clinical study.

Authors:  Wen-Qiang Zhang; Shao-Qin Han; Zhen Yuan; Ye-Teng He; Hu Zhang; Ming Zhang
Journal:  Indian J Orthop       Date:  2016 Jan-Feb       Impact factor: 1.251

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.